Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Pharmacy / Pharmacist News

APhA, Lexi-Comp Announce Release Of New Drug Information Solution For Community Pharmacists

Main Category: Pharmacy / Pharmacist
Also Included In: Pharma Industry / Biotech Industry
Article Date: 19 Oct 2007 - 15:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The American Pharmacists Association (APhA), the national professional society of pharmacists, and Lexi-Comp, a leading provider of clinical content for the health care industry, have announced the release of Lexi-Comp® ONLINE™ for Community Pharmacy. The online service, created to meet the particular needs of community pharmacists, is an affordable resource designed to provide answers to drug-related questions quickly and effectively. Using an Internet-based platform, the resource delivers the most current drug information available anywhere.

"Lexi-Comp® ONLINE™ for Community Pharmacy is a useful drug information resource for community pharmacists. It is designed for easy use, it is updated daily, and it supports community pharmacy's goal of providing medication therapy management services," says Winnie Landis, President of APhA and a community pharmacist. "This new product expands the breadth of drug information resources provided to members by APhA in collaboration with Lexi-Comp, and it is why Lexi-Comp is the official drug reference of APhA."

Lexi-Comp® ONLINE™ for Community Pharmacy includes the following databases and modules:

- Lexi-Drugs®, which contains multiple fields of information presented alphabetically such as Adverse Reactions, Dosing, Drug Pricing, FDA Special Alerts, and trade names from 125 countries

- Pediatric Lexi-Drugs®, which contains detailed guidelines compiled by pediatric specialists and up to 40 fields of information per monograph, including detailed neonatal and pediatric dosing

- Geriatric Lexi-Drugs®, which contains extensive information on drug interactions and drug dosing in the elderly

- Lexi-Interact™, a complete drug and herbal interaction analysis program that reviews a patient's entire regimen, identifies potential interactions, and provides appropriate patient management steps

- Lexi-Drug ID™, a tool that provides quick identification of unknown medications based on imprint, dosage form, shape, and color

- Adult-PALS™ and Pediatric-PALS™, which are patient advisory leaflets written at a user-friendly reading level, organized in a format ideal for patient counseling, and available in up to 18 languages

Other tools in Lexi-Comp® ONLINE™ for Community Pharmacy are a calculations module and databases on poisoning and toxicology, laboratory tests and diagnostic procedures, and natural products.

"We have tailored this product offering to provide community pharmacists with the key information they need to help improve medication safety, streamline their workflow processes, and ultimately ensure positive patient outcomes," said Steven Kerscher, President and COO for Lexi-Comp, Inc. "We are pleased to once again be collaborating with APhA to provide pharmacy professionals with trusted drug information," Kerscher added.

Lexi-Comp® ONLINE™ for Community Pharmacy can be accessed with the purchase of a single user license. (More than one pharmacist in the same pharmacy would have access, but only one person at a time.) APhA members who order the product through the APhA Web site, pharmacist.com, receive a 5% discount on the annual license fee. A free 30-day trial is also available. Pharmacists should go to http://www.pharmacist.com, click on Shop APhA, and then click on Lexi-Comp Products and Lexi-Comp ONLINE.

Since 1978, Lexi-Comp® has been providing the health care community with high-quality, affordable, and portable drug information references, available electronically and in print. Today more than 500,000 clinicians rely on Lexi-Comp for critical information on prescribing, administering, and monitoring medications. APhA and Lexi-Comp have been collaborating in the pharmacy market since 1991.

The American Pharmacists Association, founded in 1852 as the American Pharmaceutical Association, represents more than 60,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians, and others dedicated to improving medication use and advancing patient care. APhA is the first established and largest professional association of pharmacists in the United States. APhA members provide care in all practice settings, including community pharmacies, hospitals, long-term-care facilities, managed care organizations, hospice settings, and the military.

http://www.pharmacist.com




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
What Is Amoxicillin? What Does Amoxicillin Treat?
22 Jul 2009
Amoxicillin - better known by brand names such as Amoxil, Dispermox, Trimox, and Alphamox - is an antibiotic drug in the penicillin group that fights bacteria and bacterial infections...


The Latest on LASIK
The Latest on LASIK

The latest technology gives doctors the ability to map the surface of a patient's eye. That unique map then guides the laser that reshapes the eye. But this technology comes at a price.

more videos are available in our health videos section.